Comparative Pharmacology
Head-to-head clinical analysis: DICURIN PROCAINE versus ZIAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICURIN PROCAINE versus ZIAC.
DICURIN PROCAINE vs ZIAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicurin Procaine is a mercurial diuretic that inhibits sodium and chloride reabsorption in the proximal tubule and loop of Henle, leading to increased urine output. The procaine component provides local anesthetic effects.
ZIAC is a combination of bisoprolol, a cardioselective beta1-adrenergic receptor blocker, and hydrochlorothiazide, a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, reducing blood volume.
50-100 mg (as procaine penicillin G) intramuscularly once daily; severe infections: 100-200 mg IM every 12-24 hours.
ZIAC (bisoprolol fumarate/hydrochlorothiazide) 2.5 mg/6.25 mg to 10 mg/6.25 mg orally once daily, titrated at 2-week intervals based on blood pressure response. Maximum dose: 20 mg/12.5 mg per day.
None Documented
None Documented
Terminal elimination half-life: 0.5-1.5 hours (short-acting local anesthetic). Clinically, repeated doses may lead to accumulation if hepatic or renal impairment exists.
Bisoprolol: 9–12 h (terminal); HCTZ: 6–15 h (terminal); prolonged in renal impairment; steady state by 5 days
Renal excretion of unchanged drug and metabolites: 60-80% via glomerular filtration and tubular secretion; biliary excretion <5%.
Renal: bisoprolol (50% unchanged), HCTZ (≥95% unchanged); biliary/fecal: bisoprolol (≤2%)
Category C
Category C
Diuretic
Beta Blocker + Diuretic